Brief: Talphera Expected To Provide Capital Through Target Completion Of Nephro Study In Q4 Of 2025
31/03/2025 23:42
Talphera Inc TLPH.O: TALPHERA: EXPECTED TO PROVIDE CAPITAL THROUGH TARGET COMPLETION OF NEPHRO STUDY IN Q4 OF 2025 Source text: ID:nPn4ynDl9a Further company coverage: TLPH.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial